Paper41865200
Arsenic Promotes Intracellular Aβ(1-42) Accumulation via Enhanced APP but Reduced NEP Expression, and Indirectly Stimulates Extracellular Aβ Aggregation through AChE Induction in Differentiated SH-SY5Y Cells.
Leelaprachakul N and 5 others. Biol Trace Elem Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Arsenic Promotes Intracellular Aβ(1-42) Accumulation via Enhanced APP but Reduced NEP Expression, and Indirectly Stimulates Extracellular Aβ Aggregation through AChE Induction in Differentiated SH-SY5Y Cells. Papers, record 41865200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41865200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Arsenic Promotes Intracellular Aβ(1-42) Accumulation via Enhanced APP but Reduced NEP Expression, and Indirectly Stimulates Extracellular Aβ Aggregation through AChE Induction in Differentiated SH-SY5Y Cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid beta-Peptides | Major topic |
| Peptide Fragments | Major topic |
| Amyloid beta-Protein Precursor | Major topic |
| Acetylcholinesterase | Major topic |
| Neprilysin | Major topic |
| Arsenic | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Cell Differentiation | |
| GPI-Linked Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PHD/0207/2559 | The Royal Golden Jubilee Ph.D. Program | PubMed | ||
| Grant no. 49892/4778750 | Thailand Science Research and Innovation (TSRI) | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25459332 | The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. | Ann Glob Health | 2014 | https://conductscience.org/library/papers/25459332 | PubMed |
| 2 | 33249123 | Association of arsenic exposure and cognitive impairment: A population-based cross-sectional study in China. | Neurotoxicology | 2021 | https://conductscience.org/library/papers/33249123 | PubMed |
| 3 | 40507537 | Epidemiological Evidence on the Associations of Metal Exposure with Alzheimer's Disease and Related Dementias Among Elderly Women. | J Clin Med | 2025 | https://conductscience.org/library/papers/40507537 | PubMed |
| 4 | 31962196 | Positive association between soil arsenic concentration and mortality from alzheimer's disease in mainland China. | J Trace Elem Med Biol | 2020 | https://conductscience.org/library/papers/31962196 | PubMed |
| 5 | 37726351 | The association of arsenic exposure with mortality due to cancer, diabetes, Alzheimer's and congenital anomalies using Poisson regression. | Sci Rep | 2023 | https://conductscience.org/library/papers/37726351 | PubMed |
| 6 | 40278152 | Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic Studies. | J Xenobiot | 2025 | https://conductscience.org/library/papers/40278152 | PubMed |
| 7 | 39236855 | Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/39236855 | PubMed |
| 8 | 34456336 | The Amyloid-β Pathway in Alzheimer's Disease. | Mol Psychiatry | 2021 | https://conductscience.org/library/papers/34456336 | PubMed |
| 9 | 40467545 | Intracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer's disease. | Nat Commun | 2025 | https://conductscience.org/library/papers/40467545 | PubMed |
| 10 | 35563046 | Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563046 | PubMed |
| 11 | 37847125 | Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/37847125 | PubMed |
| 12 | 15100223 | Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15100223 | PubMed |
| 13 | 19228952 | Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. | J Neurosci | 2009 | https://conductscience.org/library/papers/19228952 | PubMed |
| 14 | 12972166 | Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. | Neurosci Lett | 2003 | https://conductscience.org/library/papers/12972166 | PubMed |
| 15 | 18205831 | Amyloid-cholinesterase interactions. Implications for Alzheimer's disease. | FEBS J | 2008 | https://conductscience.org/library/papers/18205831 | PubMed |
| 16 | 12927760 | Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. | Neurobiol Aging | 2003 | https://conductscience.org/library/papers/12927760 | PubMed |
| 17 | 9547230 | Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. | J Neurosci | 1998 | https://conductscience.org/library/papers/9547230 | PubMed |
| 18 | 12871588 | Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. | J Neurochem | 2003 | https://conductscience.org/library/papers/12871588 | PubMed |
| 19 | 8608006 | Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. | Neuron | 1996 | https://conductscience.org/library/papers/8608006 | PubMed |
| 20 | 23047022 | Characterisation of acetylcholinesterase release from neuronal cells. | Chem Biol Interact | 2013 | https://conductscience.org/library/papers/23047022 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 | NCBI Gene |
| ADAM10 | 102 | PubTator's text mining | https://conductscience.org/library/genes/102 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MME | 4311 | PubTator's text mining | https://conductscience.org/library/genes/4311 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41865200
GET https://conductscience.org/api/papers/v1/41865200/references?page=2